CLINICAL_TRIALS
trial_result
· 2022-10-05
Clinical Trial Update: Study of Hypofractionated Radiotherapy Alone in Locally Advanced Nonsmall Cell Lung Cancer Patients [Phase 2]
Summary
A Phase 2 clinical trial evaluating hypofractionated radiotherapy alone in locally advanced non-small cell lung cancer was terminated; results were posted in 20…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Wake Forest University Health Sciences | Conditions: Nonsmall Cell Lung Cancer, Stage II, Nonsmall Cell Lung Cancer Stage III | Phase 2 | Status: TERMINATED | Results posted: 2022-10-05